Biotech Archives - Page 744 of 795

1 minute read

This Inflammatory Disease Focused Stock Is Well Positioned For $12B Crohn’s Disease Market

August 16, 3:52 PM

Credit Suisse says that Ventyx Biosciences Inc’s (NASDAQ:VTYX) topline Phase 1 MAD data for its allosteric TYK2 inhibitor, VTX958 establishes clear differentiation from…

VTYX

1 minute read

These Depression Players Are Top Picks For $400B Mental Healthcare Market, Says Analyst

By Vandana Singh

August 16, 3:40 PM

HC Wainwright expects COMPASS Pathways Plc (NASDAQ: CMPS) and Cybin Inc (NYSE: CYBN) to be leaders in the emerging $400 billion mental healthcare market.

CMPS

1 minute read

Roche’s Polivy Combo Regime Under FDA Review For Type Of Blood Cancer

By Vandana Singh

August 16, 2:59 PM

Roche Holdings AG (OTC:RHHBY) announced that the FDA accepted its supplemental marketing application for Polivy. Polivy is being developed by Roche…

RHHBF

1 minute read

‘Statement: Zantac (ranitidine) U.S. litigation | GSK’ – gsk.com

By Benzinga Newsdesk

August 16, 2:04 PM

https://www.gsk.com/en-gb/media/press-releases/statement-zantac-ranitidine-us-litigation/

GSK

1 minute read

‘COVID public health emergency appears to be headed for extension’ -Axios Report

By Benzinga Newsdesk

August 16, 1:35 PM

https://www.axios.com/2022/08/16/covid-public-health-emergency-extension?utm_campaign=editorial&utm_source=twitter&utm_medium=social

SPY

2 minute read

NexImmune Pauses Developing Multiple Myeloma Hopeful, Citing Competition

By Vandana Singh

August 16, 12:26 PM

NexImmune Inc (NASDAQ: NEXI) cited the competitive environment in the blood cancer space as the reason for

BMY

1 minute read

Merck Bets $250M On Next-Gen Approach To mRNA For Infectious Diseases, Cancer

By Vandana Singh

August 16, 11:53 AM

Merck Co & Inc (NYSE:MRK) and Orna Therapeutics announced a collaboration agreement to discover, develop, and commercialize multiple programs, including vaccines and therapeutics…

MRK

1 minute read

FDA
News

Precipio Launches New 1-Step Technology For All HemeScreen Assays

By Benzinga Newsdesk

August 16, 11:05 AM

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces the launch of its second generation of HemeScreen panels. Precipio's customers using HemeScreen in their laboratory will have the

PRPO

1 minute read

Seagen For Sale? This Acquisition Target Is ‘Too Intriguing To Ignore,’ RBC Says

By Priya Nigam

August 16, 11:03 AM

The recent pressure on Seagen Inc.’s (NASDAQ: SGEN) stock may offer a nearer-term opportunity, but the biotech's position as an attractive strategic target is “too intriguing to ignore.”

MRK

1 minute read

FDA
News

Neurosense Therapeutics Reports Strong Patient Enrollment In Phase IIb Paradigm Trial For PrimeC For Treatment Of ALS

By Benzinga Newsdesk

August 16, 9:30 AM

-SEC Filing

NRSN